
A decision-ready briefing on six AI, technology and pharmaceutical disputes from October 27–November 2, 2026: Character.AI's Chapter 11 asset auction over state objections, a fair-use hearing in the music publishers' case against Anthropic, the FTC's fee lawsuit against Toast, the Ninth Circuit restoring the NFL Sunday Ticket liability verdict, and two generic-drug antitrust matters — one headed to trial, one settled.
| Sector | Parties | Docket | Current stage | Recent development | Next milestone |
|---|---|---|---|---|---|
| AI bankruptcy | Character Technologies, Inc. (Character.AI), debtor; state attorneys general and the U.S. Trustee objecting; Disney Worldwide Services as stalking-horse bidder | 26-11603 (BLS) (Bankr. D. Del.) | Bidding procedures approved October 30, 2026 | Judge Brendan Shannon cleared the auction calendar and left the Disney releases for later; 39 states and the District of Columbia had objected by October 28. 1 | Sale approval hearing expected November 30, 2026. 1 |
| AI copyright | Concord Music Group and other publishers v. Anthropic PBC | 5:24-cv-03811-EKL (N.D. Cal.) | Cross-motions for summary judgment argued October 21; no ruling | At an October 30 hearing, Judge Eumi Lee called Anthropic's fair-use position "slippery" and said she could not get clear answers on which categories of outputs were at issue. 4 | Ruling on the cross-motions; no date is public. |
| Tech consumer protection | Federal Trade Commission and eight states, California appearing through Los Angeles County and San Francisco, v. Toast, Inc. and four subsidiaries | 3:26-cv-12705 (N.D. Cal.) | Filed October 29, 2026 | The complaint runs 71 pages and targets a "$0" terminal offer, a $1,024.10 cancellation fee and a 99-cent diner fee. 5 | Toast's response to the complaint; no date is public. |
| Tech antitrust | Ninth Inning Inc. et al. v. National Football League, its 32 clubs and DirecTV | 24-5493, 24-5691 (9th Cir.), from 2:15-ml-02668-PSG-SK (C.D. Cal.) | Opinion filed October 30, 2026 | The panel reinstated the jury's liability verdict and ordered a new trial on damages. 2 | New damages trial in the Central District of California; no date is public. |
| Pharma antitrust | Direct purchasers of Niaspan v. AbbVie and Teva | 2:13-md-02460 (E.D. Pa.) | Summary judgment denied October 30, 2026 | Judge Timothy Savage found a genuine dispute over whether the 2005 settlement was an unlawful pay-for-delay agreement. 6 | Trial; no date is public. |
| Pharma antitrust | Cencora, Cardinal Health, McKesson and other direct purchasers v. Sanofi | 16-cv-12652 (D. Mass.) | Settlement in principle disclosed October 27, 2026 | The Lantus purchasers settled before a January trial; terms are confidential. 7 | Settlement papers and dismissal; no date is public. |
26-11603 (BLS), United States Bankruptcy Court for the District of Delaware, before Judge Brendan L. Shannon. The company filed on October 12, 2026. 15:24-cv-03811-EKL, Northern District of California, before Judge Eumi Lee. 93:26-cv-12705, Northern District of California, San Francisco Division, filed October 29, 2026. 1024-5493 and 24-5691 in the Ninth Circuit, on appeal from 2:15-ml-02668-PSG-SK in the Central District of California, where Judge Philip S. Gutierrez presided. 22:13-md-02460, Eastern District of Pennsylvania, before Judge Timothy J. Savage. 1216-cv-12652, United States District Court for the District of Massachusetts, in Boston. 14ailawsuittracker.com
bergermontague.com
wikimediafoundation.org
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.